American Region
The total estimated cost of the Global Plan in the Latin American Region is about US$1.8 billion. The funding gap is estimated at US$0.5 billion.
For 2006-2015, it is estimated that about 2 million patients in the region will be treated in DOTS programmes and 20 000 in DOTS-Plus programmes. In addition, 33 000 TB patients will be enrolled on ART.
The combined effect of all interventions will prevent about 406 000 deaths, in comparison with a situation in which no DOTS programmes are implemented.
The region is on track to reach the Stop TB Partnership's 2015 targets linked to the MDGs.
The Global Plan in the American Region
Total cost: US $1.8 billion
Country activities:
- DOTS Expansion
- DOTS-Plus
- TB/HIV
- ACSM
Patients treated: 2 million
Lives saved: 0.4 million
Available funding: US$1.3 billion
Total funding gap: US$0.5 billion
Charts
Figure 22: Estimated costs and impacts of planned intensified activities 2006-2015 [.pdf]
